UROY Fundamental Analysis - URANIUM ROYALTY CORP

Fundamental Rating

Overall UROY gets a fundamental rating of 2 out of 10. We evaluated UROY against 213 industry peers in the Oil, Gas & Consumable Fuels industry. While UROY seems to be doing ok healthwise, there are quite some concerns on its profitability. UROY does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year UROY has reported negative net income.

In the past year UROY has reported a negative cash flow from operations.

UROY had negative earnings in 4 of the past 5 years.

In the past 5 years UROY always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.36%, UROY is doing worse than 67.14% of the companies in the same industry.

UROY has a worse Return On Equity (0.36%) than 65.73% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.36%
ROE	0.36%
ROIC	N/A

ROA(3y)-0.67%

ROA(5y)-1.53%

ROE(3y)-0.79%

ROE(5y)-1.61%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

UROY has a Profit Margin (4.65%) which is in line with its industry peers.

Looking at the Gross Margin, with a value of 63.78%, UROY is in the better half of the industry, outperforming 72.30% of the companies in the same industry.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	4.65%
GM	63.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

UROY does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for UROY has been increased compared to 1 year ago.

The number of shares outstanding for UROY has been increased compared to 5 years ago.

The debt/assets ratio for UROY has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 215.47 indicates that UROY is not in any danger for bankruptcy at the moment.

UROY has a better Altman-Z score (215.47) than 99.53% of its industry peers.

UROY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

UROY has a better Debt to Equity ratio (0.00) than 84.51% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	215.47

ROIC/WACCN/A

WACC7.78%

2.3 Liquidity

UROY has a Current Ratio of 216.58. This indicates that UROY is financially healthy and has no problem in meeting its short term obligations.

UROY has a better Current ratio (216.58) than 100.00% of its industry peers.

A Quick Ratio of 16.29 indicates that UROY has no problem at all paying its short term obligations.

The Quick ratio of UROY (16.29) is better than 97.65% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	216.58
Quick Ratio	16.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

UROY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.20%.

Looking at the last year, UROY shows a very negative growth in Revenue. The Revenue has decreased by -47.81% in the last year.

EPS 1Y (TTM)-89.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-148.67%

Revenue 1Y (TTM)-47.81%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-99.97%

3.2 Future

The Earnings Per Share is expected to decrease by -32.61% on average over the next years. This is quite bad

Based on estimates for the next years, UROY will show a decrease in Revenue. The Revenue will decrease by -3.28% on average per year.

EPS Next Y-90.47%

EPS Next 2Y-49.6%

EPS Next 3Y-17.02%

EPS Next 5Y-32.61%

Revenue Next Year-59.28%

Revenue Next 2Y-36.86%

Revenue Next 3Y-39.63%

Revenue Next 5Y-3.28%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for UROY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as UROY's earnings are expected to decrease with -17.02% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-49.6%

EPS Next 3Y-17.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for UROY!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

URANIUM ROYALTY CORP

NASDAQ:UROY (6/27/2025, 8:00:02 PM)

After market: 2.3901 -0.05 (-2.05%)

2.44

-0.05 (-2.01%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)03-06 2025-03-06

Earnings (Next)09-10 2025-09-10

Inst Owners27.67%

Inst Owner Change6.1%

Ins Owners2.18%

Ins Owner ChangeN/A

Market Cap326.08M

Analysts77.5

Price Target3.48 (42.62%)

Short Float %12.75%

Short Ratio3.77

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-49.5%

Min EPS beat(2)-100%

Max EPS beat(2)0.99%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-51.79%

Min Revenue beat(2)-99.97%

Max Revenue beat(2)-3.62%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0.66%

PT rev (3m)-11.8%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)144.47%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-25.92%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	19.29
P/FCF	N/A
P/OCF	N/A
P/B	1.5
P/tB	1.5
EV/EBITDA	N/A

EPS(TTM)0

EYN/A

EPS(NY)-0.01

Fwd EYN/A

FCF(TTM)-0.27

FCFYN/A

OCF(TTM)-0.2

OCFYN/A

SpS0.13

BVpS1.63

TBVpS1.63

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.36%
ROE	0.36%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	4.65%
GM	63.78%
FCFM	N/A

ROA(3y)-0.67%

ROA(5y)-1.53%

ROE(3y)-0.79%

ROE(5y)-1.61%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	216.58
Quick Ratio	16.29
Altman-Z	215.47

F-Score3

WACC7.78%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-89.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-148.67%

EPS Next Y-90.47%

EPS Next 2Y-49.6%

EPS Next 3Y-17.02%

EPS Next 5Y-32.61%

Revenue 1Y (TTM)-47.81%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-99.97%

Revenue Next Year-59.28%

Revenue Next 2Y-36.86%

Revenue Next 3Y-39.63%

Revenue Next 5Y-3.28%

EBIT growth 1Y-114.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-87.41%

EBIT Next 3Y-0.78%

EBIT Next 5Y-41.89%

FCF growth 1Y-154.08%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-93.38%

OCF growth 3YN/A

OCF growth 5YN/A

URANIUM ROYALTY CORP (UROY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens